JP5593030B2 - 生物学的物質の調節放出 - Google Patents

生物学的物質の調節放出 Download PDF

Info

Publication number
JP5593030B2
JP5593030B2 JP2008518535A JP2008518535A JP5593030B2 JP 5593030 B2 JP5593030 B2 JP 5593030B2 JP 2008518535 A JP2008518535 A JP 2008518535A JP 2008518535 A JP2008518535 A JP 2008518535A JP 5593030 B2 JP5593030 B2 JP 5593030B2
Authority
JP
Japan
Prior art keywords
particles
biological material
emulsion
ceramic
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008518535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538217A (ja
Inventor
フィニー，キム，スザンヌ
ジャッカス，デビッド
バルベ，クリストフェ，ジェーン，アレキサンダー
コング，リンゲン
Original Assignee
オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907219A external-priority patent/AU2004907219A0/en
Application filed by オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション filed Critical オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション
Publication of JP2008538217A publication Critical patent/JP2008538217A/ja
Application granted granted Critical
Publication of JP5593030B2 publication Critical patent/JP5593030B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • B01J2/08—Gelation of a colloidal solution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21001—Chymotrypsin (3.4.21.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01005—Urease (3.5.1.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2008518535A 2004-12-20 2005-12-20 生物学的物質の調節放出 Expired - Fee Related JP5593030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004907219A AU2004907219A0 (en) 2004-12-20 Controlled release of biological entities
AU2004907219 2004-12-20
PCT/AU2005/001915 WO2006066317A1 (en) 2004-12-20 2005-12-20 Controlled release of biological entities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012243686A Division JP5727445B2 (ja) 2004-12-20 2012-11-05 生物学的物質の調節放出

Publications (2)

Publication Number Publication Date
JP2008538217A JP2008538217A (ja) 2008-10-16
JP5593030B2 true JP5593030B2 (ja) 2014-09-17

Family

ID=36601253

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008518535A Expired - Fee Related JP5593030B2 (ja) 2004-12-20 2005-12-20 生物学的物質の調節放出
JP2012243686A Expired - Fee Related JP5727445B2 (ja) 2004-12-20 2012-11-05 生物学的物質の調節放出

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012243686A Expired - Fee Related JP5727445B2 (ja) 2004-12-20 2012-11-05 生物学的物質の調節放出

Country Status (10)

Country Link
US (2) US8992986B2 (enExample)
EP (1) EP1838289B1 (enExample)
JP (2) JP5593030B2 (enExample)
KR (1) KR20070104563A (enExample)
CN (1) CN101106978A (enExample)
BR (1) BRPI0519139A2 (enExample)
CA (1) CA2591344C (enExample)
MX (1) MX2007007373A (enExample)
NZ (1) NZ556082A (enExample)
WO (1) WO2006066317A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6101683A (en) 1998-04-02 2000-08-15 Avery Dennison Corporation Loop fastener, fastener clip including same and loop fastener dispensing tool
WO2009132411A1 (en) * 2008-04-28 2009-11-05 The University Of British Columbia Polymer-free drug delivery system for implantable medical devices
NZ595185A (en) * 2009-03-27 2012-11-30 Australian Nuclear Science Tec Triggered release of a compound or composition into solution using porus particles
RU2600841C2 (ru) * 2010-08-16 2016-10-27 Острэйлиен Ньюклиар Сайенс Энд Текнолоджи Организейшн Вещества, включающие керамические частицы для доставки биомолекул
WO2017114955A2 (en) * 2015-12-31 2017-07-06 Universal Diagnostics, S.L. Systems and methods for automated, customizable sample preparation tool, software script, and calibration routine for detection of metabolites and lipids
CN107522868B (zh) * 2017-10-16 2021-01-08 湖北工业大学 环氧纳米二氧化硅/嵌段聚合物复合乳液的制备方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US20220110964A1 (en) * 2018-08-03 2022-04-14 Lemonex Inc. Pharmaceutical composition for preventing or treating atopic diseases
US20210169123A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Pouched products with enhanced flavor stability
IT202000011803A1 (it) * 2020-05-20 2021-11-20 Hudson River Biotechnology B V Particella multistrato incapsulante una molecola biologicamente attiva

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850751A (en) * 1973-02-16 1974-11-26 Corning Glass Works Enzymes immobilized on porous inorganic support materials
CH624011A5 (enExample) 1977-08-05 1981-07-15 Battelle Memorial Institute
CA1253129A (en) * 1984-02-09 1989-04-25 Thomas R. Jones Porous inorganic materials
JPH0717371B2 (ja) * 1986-09-05 1995-03-01 株式会社資生堂 球状の有機複合粘土鉱物及びその製造法
JPH05261274A (ja) * 1992-03-23 1993-10-12 Lion Corp 金属化合物の球形粒子の製造方法
JP3310291B2 (ja) 1992-08-13 2002-08-05 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 骨組織のｉｎ ｖｉｔｒｏ合成のための生物活性物質テンプレート
US5817327A (en) 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US5972384A (en) 1997-10-01 1999-10-26 University Of Maryland, Baltimore Use of biologically active glass as a drug delivery system
DE1104287T1 (de) 1998-08-13 2001-12-20 Sol-Gel Technologies Ltd., Tel Aviv Verfahren zur herstellung von mit funktionalisierten molekülen beladene oxid-mikrokapseln und die daraus erhaltenen produkte
CA2328614C (en) 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
CA2377560C (en) 1999-06-24 2010-08-24 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
JP2001038193A (ja) * 1999-07-28 2001-02-13 Nippon Millipore Kk 複合シリカマイクロカプセルの製造方法と複合シリカマイクロカプセルの芯物質の固定化と徐放作用の制御方法。
AU7881000A (en) 1999-08-16 2001-03-13 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US6303290B1 (en) 2000-09-13 2001-10-16 The Trustees Of The University Of Pennsylvania Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6485707B2 (en) 2001-02-15 2002-11-26 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6596262B2 (en) 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6544497B2 (en) 2001-02-15 2003-04-08 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
WO2003043586A2 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
WO2003092402A1 (en) 2002-04-30 2003-11-13 Solae, Llc Method of imparting high water dispersibility to protein materials and the products thereof
JP4192235B2 (ja) * 2002-04-30 2008-12-10 独立行政法人産業技術総合研究所 徐放機能を有するメソポーラス無機材料
JP2006506357A (ja) * 2002-10-11 2006-02-23 ヴェクトゥラ　リミテッド 有機高分子物質との組み合わせで無機粒子を含み、かつ固体の網目状マトリックスを形成する医薬賦形剤、その組成物、製造および使用
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
JP2005307120A (ja) * 2004-04-26 2005-11-04 Mitsubishi Chemicals Corp 徐放剤及びそれを用いた徐放材
US20090098044A1 (en) * 2004-11-15 2009-04-16 Australian Nuclear Science And Technology Organisation Solid particles from controlled destabilisation of microemulsions
KR20070097439A (ko) * 2004-11-15 2007-10-04 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 마이크로에멀션의 제어된 비안정화로부터 제조된 고형분입자

Also Published As

Publication number Publication date
JP5727445B2 (ja) 2015-06-03
MX2007007373A (es) 2007-08-14
EP1838289B1 (en) 2017-12-13
EP1838289A1 (en) 2007-10-03
NZ556082A (en) 2009-09-25
CN101106978A (zh) 2008-01-16
WO2006066317A8 (en) 2006-08-24
US9717688B2 (en) 2017-08-01
US20150147401A1 (en) 2015-05-28
CA2591344C (en) 2015-09-29
EP1838289A4 (en) 2011-12-14
US8992986B2 (en) 2015-03-31
US20090252808A1 (en) 2009-10-08
JP2008538217A (ja) 2008-10-16
BRPI0519139A2 (pt) 2008-12-30
CA2591344A1 (en) 2006-06-29
WO2006066317A1 (en) 2006-06-29
JP2013047264A (ja) 2013-03-07
KR20070104563A (ko) 2007-10-26

Similar Documents

Publication Publication Date Title
JP5727445B2 (ja) 生物学的物質の調節放出
Machado et al. Preparation of calcium alginate nanoparticles using water-in-oil (W/O) nanoemulsions
EP1257259B1 (en) Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
KR101205481B1 (ko) 방출 가능한 도펀트를 함유한 입자
US5464634A (en) Red blood cell surrogate
JP2007514519A (ja) ポリマー及び帯電ナノ粒子からなるマイクロカプセルを製造する方法
US7491263B2 (en) Storage assembly
US20090246279A1 (en) Particles having hydrophobic material therein
US20020055461A1 (en) Stable polymer aqueous/aqueous emulsion system and uses thereof
AU2009342893B2 (en) Triggered release
JP2012532860A (ja) 架橋されたタンパク質ナノ結晶、架橋されたタンパク質ナノ凝集体およびそれらの調製方法
JPH02149334A (ja) 極小粒子形の蛋白質の分散性コロイド系の調製方法
Cellesi et al. Sol–gel synthesis at neutral pH in W/O microemulsion: a method for enzyme nanoencapsulation in silica gel nanoparticles
Umebara et al. Catalase-driven protein microtube motors with different exterior surfaces as ultrasmall biotools
JP2008088158A (ja) 親水性活性物質含有微粒子の製造方法
AU2005318928B2 (en) Controlled release of biological entities
HK1104792B (en) Controlled release of biological entities
HK1104792A (en) Controlled release of biological entities
SK76595A3 (en) Antacid composition and method of production
Eilleia et al. Examining insulin adsorption onto mesoporous silica microparticles for oral delivery
AU2005304290B2 (en) Solid particles from controlled destabilisation of microemulsions
AU2001235236B2 (en) Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
CN116869151A (zh) 一种pH响应多肽聚赖氨酸-ATP凝聚体纳米递送系统及制备方法和应用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120403

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120703

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121105

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20121225

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140318

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140804

R150 Certificate of patent or registration of utility model

Ref document number: 5593030

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees